{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:33:14Z","timestamp":1793226794446,"version":"4.5.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.jp","jtcvsopen.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JTCVS Open"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.xjon.2026.101920","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T16:30:34Z","timestamp":1780677034000},"page":"101920","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Survival and outcomes after nonoperative management of operable non\u2013small cell lung cancer"],"prefix":"10.1016","volume":"32","author":[{"given":"Raffaele","family":"Rocco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf Martz","family":"Sulague","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Krishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clark B.","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philicia","family":"Moonsamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Brownlee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harmik J.","family":"Soukiasian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.xjon.2026.101920_bib1","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.chest.2025.06.023","article-title":"Management of patients with early-stage non-small cell lung cancer: an American College of Chest Physicians Clinical Practice Guideline","volume":"168","author":"Howington","year":"2025","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.xjon.2026.101920_bib2","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.athoracsur.2016.01.077","article-title":"The natural history of operable non-small cell lung cancer in the national cancer database","volume":"101","author":"Rosen","year":"2016","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.xjon.2026.101920_bib3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1378\/chest.06-3096","article-title":"Natural history of stage I non-small cell lung cancer: implications for early detection","volume":"132","author":"Raz","year":"2007","journal-title":"Chest"},{"issue":"10299","key":"10.1016\/j.xjon.2026.101920_bib4","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","article-title":"Lung cancer","volume":"398","author":"Thai","year":"2021","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.xjon.2026.101920_bib5","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJMoa2302983","article-title":"Perioperative pembrolizumab for early-stage non-small-cell lung cancer","volume":"389","author":"Wakelee","year":"2023","journal-title":"N Engl J Med"},{"issue":"10459","key":"10.1016\/j.xjon.2026.101920_bib6","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(24)01756-2","article-title":"Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"404","author":"Spicer","year":"2024","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.xjon.2026.101920_bib7","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJMoa2502931","article-title":"Overall survival with neoadjuvant nivolumab plus chemotherapy in lung cancer","volume":"393","author":"Forde","year":"2025","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.xjon.2026.101920_bib8","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.15724","article-title":"Comparison of long-term survival of patients with early-stage non\u2013small cell lung cancer after surgery vs stereotactic body radiotherapy","volume":"2","author":"Chi","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.xjon.2026.101920_bib9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.radonc.2019.01.027","article-title":"Multi-institutional analysis of stereotactic body radiation therapy for operable early-stage non-small cell lung carcinoma","volume":"134","author":"Kann","year":"2019","journal-title":"Radiother Oncol"},{"issue":"17","key":"10.1016\/j.xjon.2026.101920_bib10","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.3390\/cancers15174382","article-title":"Real-world results of stereotactic body radiotherapy for 399 medically operable patients with stage I histology-proven non-small cell lung cancer","volume":"15","author":"Onishi","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.xjon.2026.101920_bib11","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1200\/JOP.2017.028894","article-title":"Stereotactic body radiotherapy for early-stage non-small-cell lung cancer: American Society of Clinical Oncology endorsement of the American Society for Radiation Oncology Evidence-Based Guideline Summary","volume":"14","author":"Schneider","year":"2018","journal-title":"J Oncol Pract"},{"issue":"2","key":"10.1016\/j.xjon.2026.101920_bib12","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/0284186X.2017.1374558","article-title":"Survival of localized NSCLC patients without active treatment or treated with SBRT","volume":"57","author":"Jeppesen","year":"2018","journal-title":"Acta Oncol"},{"issue":"11","key":"10.1016\/j.xjon.2026.101920_bib13","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1080\/0284186X.2018.1481292","article-title":"Stereotactic body radiation therapy (SBRT) improves local control and overall survival compared to conventionally fractionated radiation for stage I non-small cell lung cancer (NSCLC)","volume":"57","author":"von Reibnitz","year":"2018","journal-title":"Acta Oncol"},{"issue":"10","key":"10.1016\/j.xjon.2026.101920_bib14","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/S1470-2045(21)00401-0","article-title":"Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery","volume":"22","author":"Chang","year":"2021","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.xjon.2026.101920_bib15","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1001\/jama.2019.11058","article-title":"Systemic therapy for locally advanced and metastatic non\u2013small cell lung cancer: a review","volume":"322","author":"Arbour","year":"2019","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.xjon.2026.101920_bib16","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/jamaoncol.2025.1115","article-title":"Neoadjuvant PD-1 and PD-L1 blockade with chemotherapy for borderline resectable and unresectable stage III non\u2013small cell lung cancer","volume":"11","author":"Ricciuti","year":"2025","journal-title":"JAMA Oncol"},{"issue":"5","key":"10.1016\/j.xjon.2026.101920_bib17","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.ejcts.2005.06.046","article-title":"Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer","volume":"28","author":"Birim","year":"2005","journal-title":"Eur J Cardiothorac Surg"}],"container-title":["JTCVS Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666273626003438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666273626003438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:10:47Z","timestamp":1793225447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666273626003438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":17,"alternative-id":["S2666273626003438"],"URL":"https:\/\/doi.org\/10.1016\/j.xjon.2026.101920","relation":{},"ISSN":["2666-2736"],"issn-type":[{"value":"2666-2736","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival and outcomes after nonoperative management of operable non\u2013small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"JTCVS Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xjon.2026.101920","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Association for Thoracic Surgery.","name":"copyright","label":"Copyright"}],"article-number":"101920"}}